Oral administration of a casein matrix containing β-casofensin protects the intestinal barrier in two preclinical models of gut diseases

Oral administration of a casein matrix containing β-casofensin protects the intestinal barrier in two preclinical models of gut diseases

β-Casofensin is a milk-derived bioactive peptide that interacts with intestinal goblet cells. We aimed to determine whether β-casofensin could prevent intestinal dysfunctions induced by neonatal maternal separation (NMS) and whether it retains its protective effects when administered in a casein mat...

Full description

Bibliographic Details
Main Authors: Claudine Bessette, Gwénaële Henry, Soraya Sekkal, Bérengère Benoit, Jérémie Bruno, Emmanuelle Meugnier, Laurent Ferrier, Vassilia Théodorou, Joelle Léonil, Pascale Plaisancié
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:Journal of Functional Foods
Subjects:
Milk-derived bioactive peptide
β-CN(94–123)
MUC2
Mucus
Intestinal protection
Functional food
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464616302833

Internet

http://www.sciencedirect.com/science/article/pii/S1756464616302833

Similar Items